A citation-based method for searching scientific literature


List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
Stefano Monti, Kerry J Savage, Jeffery L Kutok, Friedrich Feuerhake, Paul Kurtin, Martin Mihm, Bingyan Wu, Laura Pasqualucci, Donna Neuberg, Ricardo C T Aguiar,[...]. Blood 2005
588
50

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Anas Younes, Laurie H Sehn, Peter Johnson, Pier Luigi Zinzani, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh,[...]. J Clin Oncol 2019
226
50

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Martine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, Katerina Bakunina, Rogier Mous, Pieternella J Lugtenburg, Daan Dierickx, Gustaaf W van Imhoff, Joost S P Vermaat, Erik A F Marijt,[...]. Haematologica 2020
15
50

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
50

The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Chloé B Steen, Bogdan A Luca, Mohammad S Esfahani, Armon Azizi, Brian J Sworder, Barzin Y Nabet, David M Kurtz, Chih Long Liu, Farnaz Khameneh, Ranjana H Advani,[...]. Cancer Cell 2021
29
50

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Daisuke Ennishi, Aixiang Jiang, Merrill Boyle, Brett Collinge, Bruno M Grande, Susana Ben-Neriah, Christopher Rushton, Jeffrey Tang, Nicole Thomas, Graham W Slack,[...]. J Clin Oncol 2019
153
50

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
50

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Stuart E Lacy, Sharon L Barrans, Philip A Beer, Daniel Painter, Alexandra G Smith, Eve Roman, Susanna L Cooke, Camilo Ruiz, Paul Glover, Suzan J L Van Hoppe,[...]. Blood 2020
129
50

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, David W Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin,[...]. J Clin Oncol 2021
52
50

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wyndham H Wilson, George W Wright, Da Wei Huang, Brendan Hodkinson, Sriram Balasubramanian, Yue Fan, Jessica Vermeulen, Martin Shreeve, Louis M Staudt. Cancer Cell 2021
39
50

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Andreas Rosenwald, George Wright, Wing C Chan, Joseph M Connors, Elias Campo, Richard I Fisher, Randy D Gascoyne, H Konrad Muller-Hermelink, Erlend B Smeland, Jena M Giltnane,[...]. N Engl J Med 2002
50

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
754
50

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
270
50

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Andrew Davies, Thomas E Cummin, Sharon Barrans, Tom Maishman, Christoph Mamot, Urban Novak, Josh Caddy, Louise Stanton, Shamim Kazmi-Stokes, Andrew McMillan,[...]. Lancet Oncol 2019
112
50

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.
David W Scott, George W Wright, P Mickey Williams, Chih-Jian Lih, William Walsh, Elaine S Jaffe, Andreas Rosenwald, Elias Campo, Wing C Chan, Joseph M Connors,[...]. Blood 2014
395
50

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
50

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
50

Diffuse Large B-Cell Lymphoma.
Laurie H Sehn, Gilles Salles. N Engl J Med 2021
117
50

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma.
Wei Zhang, Li Yang, Yu' Qi Guan, Ke' Feng Shen, Mei' Lan Zhang, Hao' Dong Cai, Jia' Chen Wang, Ying Wang, Liang Huang, Yang Cao,[...]. BMC Cancer 2020
5
25

Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels.
Tobias Roider, Julian Seufert, Alexey Uvarovskii, Felix Frauhammer, Marie Bordas, Nima Abedpour, Marta Stolarczyk, Jan-Philipp Mallm, Sophie A Herbst, Peter-Martin Bruch,[...]. Nat Cell Biol 2020
46
25

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
Hua You, Zijun Y Xu-Monette, Li Wei, Harry Nunns, Máté L Nagy, Govind Bhagat, Xiaosheng Fang, Feng Zhu, Carlo Visco, Alexandar Tzankov,[...]. Oncoimmunology 2021
3
33

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5.
Benoît Manfroi, Maria De Grandis, Jérôme Moreaux, Sébastien Tabruyn, Jean-François Mayol, Mélanie Quintero, Christian Righini, Nathalie Sturm, Michel Aurrand-Lions, Bertrand Huard. Blood Adv 2021
2
50

CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Colm Keane, Devinder Gill, Frank Vari, Donna Cross, Lynn Griffiths, Maher Gandhi. Am J Hematol 2013
60
25

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
25

Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Moritz Ernst, Annika Oeser, Burcu Besiroglu, Julia Caro-Valenzuela, Mohamed Abd El Aziz, Ina Monsef, Peter Borchmann, Lise J Estcourt, Nicole Skoetz, Marius Goldkuhle. Cochrane Database Syst Rev 2021
5
25

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
M J Kersten, W Kraan, J Doorduijn, J Bromberg, K Lam, P M Kluin, B J van der Holt, M Spaargaren, S T Pals. Blood Cancer J 2014
7
25

Immune ageing at single-cell resolution.
Denis A Mogilenko, Irina Shchukina, Maxim N Artyomov. Nat Rev Immunol 2022
19
25

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
S Ciavarella, M C Vegliante, M Fabbri, S De Summa, F Melle, G Motta, V De Iuliis, G Opinto, A Enjuanes, S Rega,[...]. Ann Oncol 2018
64
25

Treatment of Diffuse Large B-Cell Lymphoma.
Kana Miyazaki. J Clin Exp Hematop 2016
43
25

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Maysaa Abdulla, Andrei Alexsson, Christer Sundström, Claes Ladenvall, Larry Mansouri, Cecilia Lindskog, Mattias Berglund, Lucia Cavelier, Gunilla Enblad, Peter Hollander,[...]. Acta Oncol 2021
5
25

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
Anne M R Schrader, Patty M Jansen, Rein Willemze, Maarten H Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F Somers, Hendrik Veelken, Ronald van Eijk, Willem Kraan, Marie José Kersten,[...]. Blood 2018
44
25

Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry.
Dmitry R Bandura, Vladimir I Baranov, Olga I Ornatsky, Alexei Antonov, Robert Kinach, Xudong Lou, Serguei Pavlov, Sergey Vorobiev, John E Dick, Scott D Tanner. Anal Chem 2009
738
25

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
Roni Shouval, Ana Alarcon Tomas, Joshua A Fein, Jessica R Flynn, Ettai Markovits, Shimrit Mayer, Aishat Olaide Afuye, Anna Alperovich, Theodora Anagnostou, Michal J Besser,[...]. J Clin Oncol 2022
12
25

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
M K Gandhi, T Hoang, S C Law, S Brosda, K O'Rourke, J W D Tobin, F Vari, V Murigneux, L Fink, J Gunawardana,[...]. Blood 2021
23
25

A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
Thomas Yssing Michaelsen, Julia Richter, Rasmus Froberg Brøndum, Wolfram Klapper, Hans Erik Johnsen, Mads Albertsen, Karen Dybkær, Martin Bøgsted. Blood Adv 2018
8
25

In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Lukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, Pauline Biesemans, Julio Finalet Ferreiro, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Giorgio Cattoretti,[...]. Cancer Immunol Immunother 2020
19
25

Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.
Tianqi Xu, Jia Chai, Kaijing Wang, Qingge Jia, Yixiong Liu, Yingmei Wang, Junpeng Xu, Kangjie Yu, Danhui Zhao, Jing Ma,[...]. Front Oncol 2021
2
50

Dynamic chromatin regulatory landscape of human CAR T cell exhaustion.
David G Gennert, Rachel C Lynn, Jeff M Granja, Evan W Weber, Maxwell R Mumbach, Yang Zhao, Zhana Duren, Elena Sotillo, William J Greenleaf, Wing H Wong,[...]. Proc Natl Acad Sci U S A 2021
13
25

Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing.
Sally E Trabucco, Ethan S Sokol, Sophia L Maund, Jay A Moore, Garrett M Frampton, Lee A Albacker, Mikkel Z Oestergaard, Jeffrey Venstrom, Laurie H Sehn, Christopher R Bolen. Future Oncol 2021
1
100

Precision medicine in diffuse large B-cell lymphoma: hitting the target.
Joost S Vermaat, Steven T Pals, Anas Younes, Martin Dreyling, Massimo Federico, Igor Aurer, John Radford, Marie José Kersten. Haematologica 2015
18
25

Stromal gene signatures in large-B-cell lymphomas.
G Lenz, G Wright, S S Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, N Goldschmidt, J Iqbal,[...]. N Engl J Med 2008
25

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
Colm Keane, Frank Vari, Mark Hertzberg, Kim-Anh Lê Cao, Michael R Green, Erica Han, John F Seymour, Rodney J Hicks, Devinder Gill, Pauline Crooks,[...]. Lancet Haematol 2015
62
25

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Franck Morschhauser, Pierre Feugier, Ian W Flinn, Robin Gasiorowski, Richard Greil, Árpád Illés, Nathalie A Johnson, Jean-François Larouche, Pieternella J Lugtenburg, Caterina Patti,[...]. Blood 2021
35
25

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Ash A Alizadeh, Andrew J Gentles, Alvaro J Alencar, Chih Long Liu, Holbrook E Kohrt, Roch Houot, Matthew J Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H Advani,[...]. Blood 2011
149
25

Whole transcriptome analysis with sequencing: methods, challenges and potential solutions.
Zhihua Jiang, Xiang Zhou, Rui Li, Jennifer J Michal, Shuwen Zhang, Michael V Dodson, Zhiwu Zhang, Richard M Harland. Cell Mol Life Sci 2015
69
25

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
Georg Lenz, Inga Nagel, Reiner Siebert, Anna V Roschke, Warren Sanger, George W Wright, Sandeep S Dave, Bruce Tan, Hong Zhao, Andreas Rosenwald,[...]. J Exp Med 2007
143
25

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Anne M R Schrader, Ruben A L de Groen, Rein Willemze, Patty M Jansen, Koen D Quint, Tom van Wezel, Ronald van Eijk, Dina Ruano, Cornelis P Tensen, Esther Hauben,[...]. Virchows Arch 2022
6
25

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Anja Mottok, George Wright, Andreas Rosenwald, German Ott, Colleen Ramsower, Elias Campo, Rita M Braziel, Jan Delabie, Dennis D Weisenburger, Joo Y Song,[...]. Blood 2018
39
25

Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
Rong Shen, Peng-Peng Xu, Nan Wang, Hong-Mei Yi, Lei Dong, Di Fu, Jin-Yan Huang, Heng-Ye Huang, Anne Janin, Shu Cheng,[...]. Clin Transl Med 2020
21
25

Gene Expression Detection Assay for Cancer Clinical Use.
Shavira Narrandes, Wayne Xu. J Cancer 2018
43
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.